XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 101 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $603,000 | +0.2% | 245,957 | +66.2% | 0.00% | – |
| Q2 2021 | $602,000 | -57.8% | 147,965 | -53.2% | 0.00% | – |
| Q1 2021 | $1,426,000 | +605.9% | 316,214 | +668.4% | 0.00% | – |
| Q4 2020 | $202,000 | +215.6% | 41,150 | +279.0% | 0.00% | – |
| Q3 2020 | $64,000 | -43.9% | 10,858 | -74.7% | 0.00% | – |
| Q2 2020 | $114,000 | +1800.0% | 42,903 | +1259.8% | 0.00% | – |
| Q1 2020 | $6,000 | -98.1% | 3,155 | -93.0% | 0.00% | – |
| Q4 2019 | $315,000 | +303.8% | 44,790 | +468.0% | 0.00% | – |
| Q3 2019 | $78,000 | +1200.0% | 7,885 | +1407.6% | 0.00% | – |
| Q2 2019 | $6,000 | -98.9% | 523 | -99.0% | 0.00% | – |
| Q1 2019 | $534,000 | +193.4% | 53,116 | +395.9% | 0.00% | – |
| Q4 2018 | $182,000 | -22.6% | 10,710 | -20.0% | 0.00% | – |
| Q3 2018 | $235,000 | +1707.7% | 13,386 | +1751.5% | 0.00% | – |
| Q2 2018 | $13,000 | – | 723 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 4,172,459 | $20,528,000 | 1.31% |
| DELTEC ASSET MANAGEMENT LLC | 693,870 | $3,414,000 | 0.52% |
| Alpine Global Management, LLC | 350,000 | $1,722,000 | 0.35% |
| Redmile Group, LLC | 2,397,441 | $11,795,000 | 0.14% |
| Kamunting Street Capital Management, L.P. | 43,833 | $216,000 | 0.11% |
| IHT Wealth Management, LLC | 250,798 | $1,234,000 | 0.10% |
| SEARLE & CO. | 34,000 | $167,000 | 0.08% |
| GPS Wealth Strategies Group, LLC | 46,025 | $226,000 | 0.08% |
| ArrowMark Colorado Holdings LLC | 1,981,909 | $9,751,000 | 0.08% |
| Gladstone Institutional Advisory LLC | 51,500 | $253 | 0.05% |